Protease inhibitor-induced lipodystrophy

Journal of the American Academy of Dermatology

Volumn 40, Issue 4, 1999, Pages 635-636

  Williamson, K ^a   Reboli, A C ^a   Manders, S M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; ETHINYLESTRADIOL; INDINAVIR; LAMIVUDINE; NORGESTREL; PROTEINASE INHIBITOR; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CUSHING DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; OBESITY; PRIORITY JOURNAL;

EID: 0032994673     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70452-4     Document Type: Article

References (17)

1. AS Fauci E Braunwald KJ Isselbacher JD Wilson JB Martin DL Kasper Harrison’s Principles of internal medicine 14th ed 1998 McGraw-Hill New York 620 2044
2. KD Miller E Jones JA Yanovski R Shankar I Feuerstein J. Falloon Visceral abdominal-fat accumulation associated with use of indinavir Lancet 351 1998 871 875
3. VR Roth S Kravcik JB. Angel Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors Clin Infect Dis 27 1998 65 67
4. A Carr K Samaras S Burton M Law J Freund DJ Chisholm A syndrome of peripheral lipodystrophy, hyperlipidaemia, and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51 F58
5. A Carr K Samaras DJ Chisholm DA. Cooper Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance Lancet 351 1998 1881 1883
6. R Striker D Conlin M Marx L. Wiviott Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors Clin Infect Dis 27 1998 218 220
7. R Viraben C. Aquilina Indinavir-associated lipodystrophy AIDS 12 1998 F37 F39
8. KK Miller PA Daly D Sentochnik J Doweiko M Samore NO Basgoz Pseudo-Cushing’s syndrome in human immunodeficiency virus-infected patients Clin Infect Dis 27 1998 68 72
9. A De Luca R Murri F Damiano A Ammassari A Antinori “Buffalo hump” in HIV-1 infection Lancet 352 1998 320
10. RL Hengel JA Geary MA Vuchetich AS Swartz PS Brachman NB Watts Multiple symmetrical lipomatosis associated with protease inhibitor therapy Fifth Conference on Retroviruses and Opportunistic Infections 1998 156 [abstract No. 407]
11. A. Huff Protease inhibitor side effects take people by surprise GMHC Treat Issues 12 1 1997-98 Winter 25 27
12. JC Lo K Mulligan VW Tai H Algren M Schambelan “Buffalo hump” in men with HIV-1 infection Lancet 351 1998 867 870
13. M Mann T Piazza-Hepp E Koller C. Gibert Abnormal fat distribution in AIDS patients following protease inhibitor therapy: FDA summary Fifth Conference on Retroviruses and Opportunistic Infections 1998 157 [abstract No. 412]
14. HE Rosenberg J Mulder KA Sepkowitz MF Giordano “Protease-paunch” in HIV+ persons receiving protease inhibitor therapy: incidence, risks, and endocrinologic evaluation Fifth Conference on Retroviruses and Opportunistic Infections 1998 156 [abstract No. 408]
15. SA Danner A Carr J Leonard Safety, pharmacokinetics and preliminary efficacy of ritonavir, an inhibitor of HIV-1 protease N Engl J Med 333 1995 1528 1533
16. SM Hammer KE Squires MD Hughes A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less N Engl J Med 337 1997 725 733
17. CS Davidson Med consultant 52nd ed Physician’s desk reference 1998 Medical Economics Montvale (NJ)